Holen Sie sich die Stockscreener-App
51.10
3.00%
-1.58
Handel nachbörslich:
51.15
0.05
+0.10%
Schlusskurs vom Vortag:
$52.68
Offen:
$51.41
24-Stunden-Volumen:
3.18M
Relative Volume:
0.60
Marktkapitalisierung:
$9.17B
Einnahmen:
$1.27B
Nettoeinkommen (Verlust:
$-245.03M
KGV:
-36.32
EPS:
-1.4071
Netto-Cashflow:
$-245.36M
1W Leistung:
-7.34%
1M Leistung:
+19.90%
6M Leistung:
-40.99%
1J Leistung:
-4.97%
1-Tages-Spanne:
$50.38
$51.91
1-Wochen-Bereich:
$50.03
$57.40
52-Wochen-Spanne:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
51.10 | 9.45B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
158.49 | 26.21B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
47.49 | 9.38B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.18 | 7.06B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
25.23 | 4.93B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Jefferies | Underperform |
| 2026-04-13 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-19 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Multiple Class A Common sales reported by holders (NASDAQ: TEM) - Stock Titan
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 - The Joplin Globe
Artificial Intelligence Stocks Worth WatchingApril 27th - MarketBeat
Tempus AI (TEM) Proxy filing Summary - Quartr
Tempus AI will acquire Paige for $81.25M - MSN
Tempus AI, Inc. $TEM Stake Cut by Renaissance Capital LLC - MarketBeat
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy? - Zacks Investment Research
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? - MSN
Artificial Intelligence Stocks To ConsiderApril 26th - MarketBeat
Can Tempus AI’s (TEM) USC Partnership Quietly Redefine Its Clinical Data Moat? - simplywall.st
Best Artificial Intelligence Stocks To Watch NowApril 25th - MarketBeat
TEM Stock Quote Price and Forecast - CNN
Tempus AI Nears Profitability as Operating Leverage Emerges - The Globe and Mail
Artificial Intelligence Stocks To Watch NowApril 24th - MarketBeat
Tempus AI Stock Faces a New Test as USC Deal Opens a 1.5 Million-Visit Door - TechStock²
Tempus AI (TEM) Stock Drops 7% Despite Landmark USC Medical Partnership - MEXC Exchange
Tempus AI (TEM) Stock Slides Even As USC Inks Major AI Health Deal - MEXC
Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035F - GlobeNewswire Inc.
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Volatility? - Yahoo Finance
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine - BioSpace
Tempus AI shares gain after expanded partnership with Gilead - msn.com
Tempus AI Stock Falls After USC Deal, Putting Its Cancer Data Push To The Test - TechStock²
Healthcare AI Firm Sued Over Alleged Unlawful Disclosures of Genetic Data - The HIPAA Journal
Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights - PharmiWeb.com
Promising Artificial Intelligence Stocks To Add to Your WatchlistApril 23rd - MarketBeat
USC and Tempus AI partner to advance precision medicine - News-Medical
FDA clears AI lung cancer tool; first U.S. sites set for Q3 - Stock Titan
Cathie Wood Is Loading Up on These 3 Next-Gen Tech Stocks - Yahoo Finance
USC and Tempus Join Forces in Strategic Partnership to Accelerate Innovation in Research and Patient Care - Bioengineer.org
TEM Stock Price and Chart — NASDAQ:TEM - TradingView
Tempus AI partners with USC’s Keck Medicine on precision care - Investing.com
TEM (Tempus AI Inc.) tops EPS estimates and posts 83 percent year over year revenue growth, shares fall 3.53 percent today.Crowd Risk Alerts - Xã Thanh Hà
Is Tempus AI (TEM) Pricing Reflect Its DCF Upside And Premium Sales Multiple - simplywall.st
Promising Artificial Intelligence Stocks To Keep An Eye OnApril 21st - MarketBeat
Tempus AI Inc. (TEM): Nancy Pelosi Likes This AI-Powered Medicine Company - Insider Monkey
Hims & Hers Builds Scalable Data-Driven Personalized Care Platform - TradingView
Tempus to Report First Quarter 2026 Financial Results on May 5 - BioSpace
Press Release: Tempus to Report First Quarter 2026 Financial Results on May 5 - Moomoo
Tempus AI (TEM) Stock: Growth Outlook (On the Radar) 2026-04-20High Interest Stocks - Xã Thanh Hà
Artificial Intelligence Stocks To Add to Your WatchlistApril 20th - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 29.59% Potential Upside in the Healthcare Information Sector - DirectorsTalk Interviews
Tempus AI, Inc. (NASDAQ:TEM) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Tempus AI stock gains following the ALERT trial result announcement - MSN
Gilead (GILD), Tempus AI (TEM) expand multi-year oncology R&D collaboration - MSN
Here’s What TD Cowen Thinks About Tempus AI Inc (TEM) Stock - Insider Monkey
Best Artificial Intelligence Stocks Worth WatchingApril 19th - MarketBeat
Promising Artificial Intelligence Stocks To Watch TodayApril 18th - MarketBeat
Tempus AI stock near 1-year low: Cathie Wood’s ARK buys more while offloading Nvidia, Meta, other tech plays - MSN
Artificial Intelligence Stocks To Follow NowApril 17th - MarketBeat
Tempus AI (NASDAQ:TEM) Shares Down 5.2%Should You Sell? - MarketBeat
Tempus AI Expands Strategic Partnership Amid Oncology Boom - TradingView
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.22%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):